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Aims. Oxidative stress is known to induce early replicative senescence. Senescence has been 
proposed to work as a barrier to immortalization and tumor development. Here, we aimed to 
evaluate the impact of the loss of peroxisome proliferator activated receptor γ co-activator 1α 
(PGC-1α), a master regulator of oxidative metabolism and mitochondrial reactive oxygen 
species (ROS) generation, on replicative senescence a d immortalization in mouse embryonic 
fibroblasts (MEFs). Results. We found that primary MEFs lacking PGC-1α showed higher 
levels of ROS than wild-type MEFs at all cell passages tested. The elevated production of ROS 
was associated with higher levels of oxidative DNA damage and the increased formation of 
DNA double-strand breaks. Evaluation of the induction of DNA repair systems in response to γ-
radiation indicated that the loss of PGC-1α also resulted in a small but significant reduction in 
their activity. DNA damage induced the early activation of senescence markers, including an 
increase in the number of β-galactosidase-positive cells, the induction of p53 hosphorylation, 
and the increase in p16 and p19 protein. These changes were, however, not sufficient to reduce 
proliferation rates of PGC-1α-deficient MEFs at any cell passage tested. Moreover, PGC-1α-
deficient cells escaped replicative senescence. Innovation & Conclusion: PGC-1α plays an 
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Introduction 
Cellular senescence was first described as the statof a stable long-term loss of replicative 
capacity resulting from prolonged replication of cells in culture [1]. This form of senescence, 
termed replicative senescence, occurs in cultured human cells that reach an intolerable telomeric 
shortening [2], while in mouse embryonic fibroblasts (MEFs) it is independent of telomeres and 
more closely recapitulates the accelerated or premature senescence of human cells following 
genotoxic stress or oncogene activation, termed “ stress-induced premature senescence” and 
“ oncogene-induced senescence”, r spectively [3, 4]. 
 Senescence is ultimately driven by DNA damage [5]. Previous studies in MEFs have 
shown that both exogenously added ROS and elevated endogenous ROS production induces 
early senescence [6, 7]. Partial deficiency of s d2, encoding for mitochondrial manganese 
superoxide dismutase (MnSOD), induces mitochondrial oxidative stress and leads to an increase 
in DNA double-strand breaks (DSBs), end-to-end chromosome fusions, chromosomal 
translocations, and also loss of cell viability and proliferative capacity, indicating that 
mitochondrial oxidative stress can induce genomic instability and therefore have a profound 
effect on cancer and aging [8]. Conversely, decreasing endogenous ROS levels with the 
mitochondria-targeted antioxidant MitoQ delays replicative senescence [9]. 
 Regardless of the signals that induce senescence, two major tumor suppressor pathways, 
p53-p21WAF1 and pRb-p16INK4a, are key to control the execution and maintenance of this 
response [10, 11]. In murine cells, the ARF-p53 pathw y has a dominant role, whereas in 
human cells pRb-p16INK4a seems to be at least equally critical [12]. Both p53 and the cyclin-
dependent kinase (CDK) inhibitor p16 are activated in response to elevated ROS [13, 14]. It has 
been proposed that a positive feedback loop of mitochondrial damage, ROS production, and 
DNA damage repair (DDR) by the activation of p53 is required for the establishment of the 
growth arrest phenotype during cellular senescence [13]. The steady increase in ROS production 
by this positive feedback loop is thought to replenish short-lived DNA damage foci and to 
maintain an ongoing DDR, which are believed to be both necessary and sufficient to establish 
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dependent positive feedback loop, which reinforces th  irreversible cell cycle arrest in senescent 
cells, partly through the downregulation of large tumor suppressor kinase 1, a kinase required 
for cytokinesis [16]. 
 In the last years, several studies have supported a role for cellular senescence as a 
natural barrier to tumor development [17, 18]. Such studies include the findings that p53-driven 
senescence in mouse models can limit cancer progression in existing malignancies [19]. This 
concept has led to the proposal that inducing cellular senescence, including treatments that 
elevate intracellular ROS levels, can be of therapeutic utility in cancer. The demonstration that 
cancer cells can respond to therapeutic agents both in vivo and in vitro by inducing a senescence 
phenotype has been encouraging. However, the safety o  these approaches is still a matter of 
debate mainly because senescent cells become resistant to induced apoptotic cell death and 
senescence could be a reversible process [20]. 
 PGC-1α is a transcriptional coactivator that controls theexpression of most, if not all, 
of the metabolic pathways that allow cellular adaptation to limited nutrient availability or to 
increased metabolic demand (e.g., cold exposure and exercise) [21]. Moreover, PGC-1α boosts 
the catabolic and oxidative capacity of the cell, and coordinately induces the expression of a 
suite of antioxidant enzymes that prevents oxidative damage under these conditions [22]. As a 
result of PGC-1α induction, cells present an enhanced antioxidant cpa ity and a net reduction 
in ROS levels. Obesity and metabolic syndrome are normally associated with a decrease in 
PGC-1α activity in all the tissues and cell types where it has been investigated [23-27]. It has 
been suggested that PGC-1α down regulation may be involved in the early aging associated 
with metabolic dysfunction. Additionally, PGC-1α has been shown to interact and regulate p53 
activity [28] and its absence can promote telomere shortening and vascular senescence [29, 30] 
at least in part through TERT down-regulation [31]. Along this line, recent studies indicate that 
reduced PGC-1α levels can be a relevant factor in tumor development. It particular, its 
downregulation has been associated with the induction of c-Myc, a master regulator of cell 
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PGC-1α-/- hepatocytes showed that cancer and cell cycle were among the major functional 
pathways regulated by PGC-1α [31].  
 
 In the present study, we aimed to elucidate the role of PGC-1α in ROS-induced cellular 
senescence and immortalization using serially-passaged primary MEFs as a model system. We 
found that loss of PGC-1α resulted in elevated mitochondrial ROS production, increased 
oxidative DNA damage, genomic instability and the induction of senescence mediators 
including p53 and p16. However, these changes did not result in a reduction in cell 
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Materials and Methods 
 
Cell culture. Wild-type and PGC-1α-deficient MEFs were isolated and cultured as previously 
described [33]. Eight embryos from 3 PGC-1α+/+ litters and 8 from 3 PGC-1α-/- litters were used 
to prepare MEF cultures (8 of each). MEFs (106) were seeded in 100-cm2 dishes and cultured in 
Dulbecco’s modified Eagle’s medium (Sigma) with 10% fetal bovine serum and antibiotics. 
Cells were passaged every 72 h, counted using a hemocytometer and re-seeded at 106 cells/dish. 
This process was repeated until the cultures reached senescence. Growth rates were calculated 
with the formula ∆Growth = log2 (nf-ni), where ni is the initial cell number and nf is the final cell 
number [8]. When cultures escaped senescence and immortalized, cells were counted and 
seeded again for 5 additional passages to determine post-immortalization growth rates.  
The procedures used conformed to the Declaration of Helsinki. All animals received humane 
care according to the criteria outlined in the “Guide for the Care and Use of Laboratory 
Animals” prepared by the National Academy of Sciences and published by the National 
Institutes of Health (No. 86-23 revised 1985). Animal experimental protocols were approved by 
the CSIC Ethic’s Committee (SAF2012-37693, 333/2015) and the Consejería de Medio 
Ambiente of the Comunidad de Madrid (PROEX 317/15). 
 
Irradiation. Cell cultures plated in 8-well chamber slides (Nunc) were exposed to 3 Gy gamma 
irradiation using an irradiator (J.L. Shepherd Mark 1, San Fernando, CA). 
 
Labeling of DNA breaks. Procedures were as previously described [34]. Briefly, cells were 
incubated with biotin-11-dUTP (Thermo Scientific) in the presence of terminal deoxy-
transferase (TdT) (BioLabs). Cells were then incubated with an anti-biotin-HRP-conjugated 
antibody (Sigma), and the labeled breaks were reveal d using the DAB system (Vector Lab). 
Nuclei were stained with Nuclear Fast Red (Sigma). Photographs were taken with Nikon E90i 
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Immunofluorescence. Cell fixation, staining and analysis procedures were as previously 
described [34]. The following antibodies were used: γH2AX (05-636, Millipore), TP53BP1 
(NB100-304, Novus Biologicals) and 8-OH-deoxyguanosi e (8-OH-dG) (NB600-1508, Novus 
Biologicals). Images were acquired with Nikon E90i microscope using a DS-Q1 camera and 
analyzed with the NES Elements software. 100 cells were analyzed from 5-10 different fields in 
3 independent experiments. 
 
Mitochondrial superoxide detection. Mitochondrial superoxide was evaluated by labeling cells 
with MitoSOX Red as described [35, 36]. Images were acquired using the LSM710 spectral 
confocal microscope (Zeiss). 
 
β-galactosidase activity. Evaluation of senescence-associated β-gal (SA-β-gal) activity was 
performed at pH 6 as previously described [1]. Differential interference contrast images were 
acquired using a Nikon E90i microscope with a DS-Fi1 camera and analyzed using the NES 
Elements software. 
 
Protein extraction and western blotting. Whole cell extracts were prepared as previously 
described [37]. Proteins were separated using 12% SDS-PAGE gels and transferred to PVDF 
Hybond-P membranes (Amersham/ GE healthcare) by semidry transference using the TransBlot 
SD cell system (Bio-Rad). The following antibodies were used: p53 (sc-126, Santa Cruz), Ph-
p53 (9286), AMPK (2532) and phospho-AMPK (2535), all from Cell Signaling Technology, 
p16 (sc-1207, Santa Cruz), MnSOD (ADI-SOD-110, Enzo Life Sciences), p19 (R562, Abcam), 
cyt C (556433, BD Biosciences), and β-actin (A5441, Sigma). ImageJ software (NIH) was used 
to measure and analyze protein band intensity. 
 
RNA isolation and quantitative reverse transcription polymerase chain reaction. Total mRNA 
was extracted using TRI Reagent (Sigma) and retro-transcribed with reverse transcriptase (M-
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Master Mix (Applied Biosystems) and an Eppendorf MasterCycler RealPlex (Eppendorf). The 
following primer sets were used: 
 
Primers Sequence 5'-3' 
Forward-SESN1 CAGGAAATGCTTCGGTAAGTG  
Reverse-SESN1 GTAACTTCATCATCGTCCGA  
  
Forward -SESN2 CCACTCTCTGGCCTCCTTTG  
Reverse -SESN2 TTCAAAGCCCCCTGAGTTGT  
  
Forward -BBC3 GTACGAGCGGCGGAGACAAG 
Reverse -BBC3 CTAGTTGGGCTCCATTTCTGG 
  
Forward -BAX TTTGCTACAGGGTTTCATCC 
Reverse -BAX CCACGTCAGCAATCATCCT 
  
Forward -PMAIP1 GCAGAGCTACCACCTGAGTT 
Reverse -PMAIP1 GAGTTGAGCACACTCGTCCT 
  
Forward -GLS2 AGCTCTTCCAAAAGTGTGTG  
Reverse -GLS2 GGATGTAGGCTGCCACTTTG  
  
Forward -ALDH4 TGAAGGTGACCAATGAGCCC   
Reverse -ALDH4 GTGCATGGTTAAAGGGCGAC   
  
Forward -PARK2 TGCACAGATGTCAGGAGCCC 
Reverse -PARK2 CCTGTTGTACTGCTCTTCTCCA 
  
Forward -NDN  AAGAAGGCCCTGGAGAGTTA 
Reverse -NDN  TATTTATGGTGGGGTTGCAT 
  
Forward -GADD45A CGTAGACCCCGATAACGTGG 
Reverse -GADD45A TTCGTCACCAGCACACAGTG 
  
Forward –p16 GTC GCA GGT TCT TGG TCA CT 
Reverse –p16 CGA ATC TGC ACC GTA GTT GA 
  
Forward –p19 CCA CCG GTA TCC ACT ATG CT 
Reverse –p19 TCA GGA GCT CCA AAG CAA CT 
  
Forward –p21 GTA CTT CCT CTG CCC TGC TG 
Reverse –p21 TCT GCG CTT GGA GTG ATA GA 
  
Forward -TERC GCTGTGGGTTCTGGTCTTTTGTTC 
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Statistics. Several passages were group together for analytical purposes to compare “early” and 
“late” passages when values within the rage did not differ significantly per passage. However, 
since as for each marker and determination type this is not a constant, we refrained from 
defining them as early and late. Data are expressed as means ± SD. Statistical significance was 
evaluated by one-way analysis of variance or two-tailed upaired t test. Values were considered 








































Enhanced mitochondrial ROS production in serially passaged primary PGC-1α-deficient MEFs 
To evaluate the role of PGC-1α in cellular senescence, we used the classical 3T3 protocol [38] 
to establish the growth and immortalization time of eight individual PGC-1α+/+ and eight PGC-
1α-/- MEF cultures under standard culture conditions of 5% CO2, 20% O2 and 37ºC. These 
cultures were then used for further analysis. PGC-1α levels could be detected by western blot in 
PGC-1α+/+ MEFs but not in PGC-1α-/- MEF (Supp. Fig. 1). 
 We previously showed that PGC-1α positively regulates the expression of antioxidant 
genes, and its deficiency results in elevated mitochondrial ROS levels in various mouse primary 
cell types, including vascular endothelial cells, hepatocytes and MEFs [33]. We used western 
blotting at different cell passages to analyze the impact of PGC-1α deficiency on two of its 
targets cytochrome c (cyt c), a component of the mitochondrial electron transport chain, and 
MnSOD, a key mitochondrial detoxification enzyme. As anticipated, protein levels of cyt c and 
MnSOD at cell passage (p)1 were lower in PGC-1α-/- MEFs than in PGC-1α+/+ MEFs (Fig. 1A). 
Serial cell passaging led to a robust reduction in MnSOD levels in PGC-1α+/+ MEFs, while this 
was less evident in PGC-1α-/- MEFs (Fig. 1A,B), suggesting that MnSOD downregulation was 
at least partially attributable to PGC-1α activity. Consistently, PGC-1α levels were reduced in 
late passages (Supp. Fig. 2). By contrast, cyt c levels remained relatively stable over continuous 
passage. To evaluate whether PGC-1α-/- MEFs were metabolically compromised, we measured 
the phosphorylation status of the cellular energy sensor AMPK as an indicator of metabolic 
stress. Results showed that whereas total AMPK levels where significantly higher in PGC-1α-/- 
MEFs, the AMPK phosphorylation/AMPK total ratio was not significantly affected by the lack 
of PGC-1α across cell passages or when passages 1-3 and 4-6 were analyzed separately (Fig. 
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 We next used MitoSOX Red staining to evaluate the eff ct of serial passage on the 
levels of mitochondrial superoxide (O2
-). MitoSOX labeling increased with cell passage in both 
PGC-1α+/+ and PGC-1α-/- MEFs (Fig. 1C,D). Although not different at early passage (p1), 
MitoSOX fluorescence became higher in PGC-1α-/- MEFs than in PGC-1α+/+ MEFs upon serial 
passaging and this was more prominent at later passage  (Fig. 1C,D). This result suggested a 
synergistic effect of PGC-1α-dependent mitochondrial dysfunction on passage-induce  
oxidative stress.  
 
Deficiency of PGC-1α leads to an increase in oxidative DNA damage and the generation of 
DNA double-strand breaks 
Given that oxidative stress can result in oxidative DNA damage, we next evaluated the 
formation of 8-oxo-deoxyguanosine (8-OH-dG), a major biomarker of ROS-dependent DNA 
oxidation [34]. Quantification of the number of 8-OH-dG-containing nuclear foci in p2 and p5 
MEFs by immunofluorescence staining with a specific antibody showed that while the number 
of foci in p2 PGC-1α+/+ and PGC-1α-/- MEFs was not significantly different, the number of 
positive foci in PGC-1α-/- MEFs at p5 increased dramatically and was significantly higher than 
that in PGC-1α+/+ MEFs (Fig. 2A,B). Colocalization of 8-OH-dG nuclear foci and TP53BP1, a 
protein that is present in DNA damage repair (DDR) complexes, was used as a control for 
specificity. 
  ROS generation is linked to the formation of DNA strand breakage. ROS that are 
produced primarily by mitochondria can provoke base oxidation, abasic sites, and both DNA 
single and DSBs [39, 40]. Moreover, a significant number of the DNA single-stranded lesions 
induced by ROS are converted into DSBs, either by adirect mechanism or by the repair process 
itself [41]. We therefore next evaluated the impact of the elevated levels of ROS-induced DNA 
oxidation on the formation of DSBs. To do this, we carried out a cytochemical analysis using 
the specific activity of terminal transferase (TdT) to incorporate biotin-11-dUTP into the 3'-end 
of the DNA chain [34]. We observed that at p4, the number of cells with DNA breaks was 
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and PGC-1α-/- MEFs, respectively) (Fig. 2C,D), suggesting that the higher levels of oxidized 
DNA in PGC-1α-/- cells had a significant impact on genomic instability. 
 Of the different types of DNA lesions formed by oxidation, DSBs are the most 
deleterious, and are potent inducers of chromosomal re rrangements such as deletions, 
translocations or amplifications [42]. The phosphorylated histone, H2AFX (γH2AFX), and 
TP53BP1 are sensitive markers of DNA damage [43, 44]. When DSBs are detected, a signaling 
cascade is initiated by the phosphorylation of H2AFX by ataxia-telangiectasia mutated kinase 
near the break site, followed by the rapid recruitment of TP53BP1 to the chromatin surrounding 
the DNA lesion. Among other functions, TP53BP1 acts as a molecular scaffold in damaged 
chromatin during non-homologous end-joining repair mechanism [45].  
 We therefore determined the formation of nuclear DNA damage foci containing DSB 
repair complexes by examining for colocalization of γH2AFX and TP53BP1, part of the DNA 
repair complex [34]. We noted a good colocalization of both DDR markers. Representative 
immunofluorescence images of the individual signals can be found in Supp. Fig. 4, and the 
quantitative evaluation of their linear correlation in Supp. Fig. 5. Both PGC-1α+/+ and PGC-1α-/- 
MEFs showed higher number of cells with DNA damage foci at p5 than at p2 (Fig. 2E,F). 
Additionally, the number of DNA damage foci was significantly higher in PGC-1α-/- MEFs than 
in PGC-1α+/+ MEFs both at p2 and p5 (Fig. 2E, F).  
 
PGC-1α-deficient MEFs have reduced DNA damage repair activity 
The elevated levels of DSBs observed in PGC-1α-/- MEFs could result from the observed 
increase in oxidative DNA damage but also to other factors, in particular, a reduced capacity for 
DNA repair. To test this, we evaluated the effect of PGC-1α deficiency for the reversal of DNA 
damage. Thus, PGC-1α+/+ and PGC-1α-/- MEFs at p2 were exposed to 3 Gy irradiation and the 
number of γH2AFX nuclear foci was analyzed at different time points, from 15 min to 9 h post-
irradiation. Image quantitation revealed that at 15 min post-irradiation, 100% of PGC-1α+/+ and 
PGC-1α-/- MEFs showed nuclear foci, and the number of cells with more than 10 foci per 
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was comparable (Fig. 3A–C). The total number of cells with more than 10 nuclear foci had 
dropped significantly at 3 h both in PGC-1α+/+ and PGC-1α-/- MEFs, and the trend continued 
until 24 h, when levels reached a steady-state. Notably, at all stages post-irradiation, the number 
of cells with more than 10 nuclear foci was consistently higher in PGC-1α-/- MEFs than in PGC-
1α+/+ MEFs (Fig. 3A–C). This result suggests that PGC-1α-/- MEFs have an impaired DNA 
repair system. However, since the maximal difference between the two cell types, occurring at 3 
h post-irradiation, represented less than 10% of the total number of cells, it seems unlikely that 
this partial deficiency could play a major role in the enhanced accumulation of DSBs in serially 
passaged PGC-1α-/- MEFs.  
 
Induction of the DNA damage response was also evaluated in serially passage cells by testing 
the levels of TLS, a downstream mediator of ATM{Gardiner, 2008 #529}, we found that TLS 
levels tended to be lower in PGC-1α-/- MEFs but differences did not reach statistical 
significance (Supp. Fig. 6). 
 
Early induction of senescence in PGC-1α-deficient MEFs 
Elevated ROS levels and DNA damage can independently or cooperatively induce cellular 
senescence [46]. Therefore, we next evaluated the induction of senescence-associated β-
galactosidase (SA-β gal) activity at pH 6 as a metric of senescence. The absolute numbers of β-
gal-positive cells were higher for PGC-1α-/- MEFs than for PGC-1α+/+ MEFs from p3, and this 
was statistically significant at p6. When cell cultures stopped growing, 47% of PGC-1α-/- MEFs 
and 31% of PGC-1α+/+ MEFs were β-gal-positive (Fig. 4A,B). 
 As noted earlier, ROS and DNA damage induced premature senescence and cell cycle 
arrest depends on the activation/induction of at lest two key cell cycle regulators, p53 and p16. 
Other important factors include the CDK inhibitors p19 and p21, which are direct targets of p53, 
and widely used as senescence and cell cycle arrest markers. Thus, we monitored total and 
phosphorylated levels p53 as well as p16, p19 and p21 mRNA and protein levels by western 
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SA-β-gal activity, the levels of p53 phosphorylation were higher at early passages in PGC-1α-/- 
MEFs than in PGC-1α+/+ MEFs (Fig. 4C). Similarly, mRNA and protein levels of both p16 and 
p19, as well as p21 protein levels, were higher at early passages in PGC-1α-/- MEFs than in 
PGC-1α+/+ MEFs (Fig. 4D). These results are consistent with the induction of premature 
senescence (Fig. 4C,D). Representative western blots can be found in Supp. Fig. 7. 
 
Early senescence escape of PGC-1α-deficient MEFs 
Despite the evident early induction of senescence markers in PGC-1α-deficient MEFs, cell 
proliferation rates were not significantly different between PGC-1α+/+ and PGC-1α-/- cultures. 
Population doubling levels decreased with each passage in both cell types at similar rates and 
cultures reached senescence at the same time, cell cultures did not proliferate after 20 days in 
culture (Fig. 5A,B). In fact, immortalization occurred sign ficantly sooner for PGC-1α-/- MEFs. 
Accordingly, PGC-1α-/- MEFs immortalized on average after 9 days of senescence, whereas this 
occurred on average after 26 days for PGC-1α+/+ MEFs. Following immortalization, PGC-1α+/+ 
and PGC-1α-/- MEFs again proliferated at similar rates (Fig. 5C). This result suggests that the 
induction of p53 and the upregulation of CDK inhibitors in PGC-1α-/- MEFs was insufficient to 
adequately arrest cell proliferation. 
 
Differential expression of p53 target genes in PGC-1α deficient MEFs 
PGC-1α has been shown to directly interact and regulate p53 transcriptional activity [28]. We 
therefore questioned whether the observed impairment of cell cycle inhibition and early 
senescence escape in PGC-1α-/- MEFs could be due to a blunted induction of p53 target genes. 
To test this hypothesis, we analyzed the expression of a panel of p53-regulated genes: the pro-
apoptotic proteins bax, bbc3 (puma) and pmaip1 (noxa); the oxidative stress cell cycle 
regulators sesn1, sesn2, ndn (necdin) and gadd45a, the metabolic enzymes gls2 or aldh4, terc 
(telomerase RNA component) and park2 (parkin gene encoding an E3 ubiquitin ligase). The 
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/- MEFs than in PGC-1α+/+ MEFs while the others showed a similar tendency (Fig. 6). This 
general decrease in the expression of p53 target gen s suggests an attenuated p53 transcriptional 
activity in PGC-1α-/- MEFs and is consistent with the observed loss of cell growth arrest in the 

















The mechanisms that induce and control cellular senescence have been thoroughly investigated 
[47]and it is well established that ROS trigger oxidat ve DNA damage [48] and senescence [49]. 
While the induction of a senescence-like phenotype is currently considered a feasible cancer 
therapy approach, [50] whether it is friend or foe in tumor development remains contentious 
[51] and raises the question of whether it prevents immortalization or is the stage that precedes 
it. The link between metabolic dysfunction observed in a significant proportion of the world´s 
population [52] and the noted higher risk of tumor development [53] is also a focus of intense 
scientific debate since oxidative metabolism has been also shown to be associated with 
resistance to cancer treatments [54]. In the present tudy, we show that PGC-1α, a master 
regulator of mitochondrial function and ROS control [22] whose expression is down-regulated 
by feeding [55], plays an important role in replicat ve senescence since in its absence the 
consequent elevated ROS levels are associated with increased levels of DNA oxidation and 
DNA damage. However, cell cycle control mechanisms fail, possibly due to reduced p53 
activity, promoting de facto immortalization. 
 We first examined how serial passage of MEFs modified PGC-1α target gene 
expression. Expression of the antioxidant MnSOD gradually declined following consecutive cell 
passages. In a background of PGC-1α deficiency, MEFs showed reduced levels of MnSOD and 
the passage-dependent loss of expression was less marked than in equivalent wild-type cells, 
suggesting this is at least partially dependent on PGC-1α. PGC-1α deficiency in MEFs was 
accompanied by the increased production of mitochondrial ROS and, as expected, ROS 
production was significantly higher in PGC-1α-/- MEFs than in PGC-1α+/+ MEFs from passage 
3. Remarkably, the passage-dependent increase in ROS production in PGC-1α-/- MEFs was 
more marked than that in PGC-1α+/+ MEFs, possibly reflecting the well-characterized damaging 
effect of ROS on mitochondrial function, which rendrs mitochondria even more dysfunctional 
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 We next evaluated the impact of elevated ROS production for DNA oxidation and 
genomic instability. Consistent with the elevated lvels of ROS, we observed higher levels of 
DNA oxidation and DSBs in PGC-1α-/- MEFs. We ruled out the possibility that the increas  in 
DSBs was associated with an impaired DNA repair system since direct evaluation of the 
induction of DNA repair activities using γ-radiation showed only a marginal defect in PGC-1α-/- 
MEFs, which is not likely to be the mechanism behind the observed levels of DSBs in serially-
passaged cells. 
 Considering that both elevated ROS levels and DNA damage can induce senescence 
mediators that inhibit cell cycle progression, we monitored the activation of p53 and the 
induction of p16 and p19, consistently finding an erly activation of these senescence mediators 
in PGC-1α-/- MEFs. However, cell proliferation rates were not significantly different between 
PGC-1α+/+ and PGC-1α-/- MEFs, suggesting that downstream mediators of cell pro iferation 
were not efficiently induced. Furthermore, PGC-1α-/- MEFs immortalization was significantly 
faster, possibly suggesting a failure to adequately induce cell death. In PGC-1α+/+ cells the ratio 
p-p53/p53 was higher in “late” passages than in “early” passages as previously described. It is 
possible that in PGC-1α-/- cells since the damage occurs earlier, there is anearlier activation of 
p53, and that could explain why the ratio p-p53/p53 at “early” passages is higher in PGC-1α-/- 
than in PGC-1α+/+ MEFs. To elucidate why the p-p53/p53 ratio is not further enhanced in PGC-
1α-/- MEFs  at “late” passages despite of the evident increase in DNA damage deserves further 
investigation.  
 Taking into account that p53 plays a key role both in cell cycle arrest and ROS-induced 
apoptotic cell death [56], and that PGC-1α can operate as a coactivator of p53 transcriptional 
activity [28], we evaluated the expression levels of a panel of p53 target genes including 
inductors of cell cycle arrest and apoptosis. We found that the levels of several of these genes 
were significantly lower in PGC-1α-/- MEFs, despite the observed moderate increase in activated 
p53 in these cells, possibly suggesting that the failure to properly induce cell cycle arrest and 
pro-apoptotic gene expression may facilitate the immortalization of PGC-1α-/- MEFs. 
Additionally, the observation that the induction of p21 levels (another p53 target, and cell cycle 
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into account the level of DNA damage in these cells, a o argue in favor of a p53 dependent 
mechanism .
Still, one limitation of the study is that the nature of the mutations occurring in PGC-1α+/+ and 
PGC-1α-/- MEFs leading to immortalization has not been tested. Also, the causality of the 
increased levels of superoxide in PGC-1α on DNA damage could not be evaluated since 
antioxidant treatments per se alter the cell cycle du  to the role the cellular redox status plays in 
its control. 
 PGC-1α is recognized as a master regulator of mitochondrial function, including the 
control of mitochondrial ROS production. The long noted metabolic shift associated with tumor 
development, the Warburg effect, that makes cancer cell predominantly glycolytic has [57] 
fostered investigation on the possible role of PGC-1α in tumor development. While some 
studies attribute to PGC-1α a predominant tumor suppressor role preventing, for example, 
prostate cancer tumor metastasis [58], others find just the opposite in breast cancer [59], making 
it necessary further studies to define the molecular and functional basis for these differences. 
Our results highlight a novel aspect of how PGC-1α could impact tumor development by 
promoting ROS-induced DNA damage and early immortalization, possibly fostered by a 
defective activation of p53 and the senescence program. 
 
Highlights 
We evaluated the role of PGC-1α on the induction of cellular senescence and immortalization. 
-The increase in ROS production associated with cell passage in MEFs is exacerbated in PGC-
1α-/- MEFs. 
-PGC-1α-/- MEFs accumulate with cell passage higher levels of oxidative DNA damage than 
PGC-1α-+/+ MEFs. 
-Serially passaged PGC-1α-/- MEFs show in early induction of senescence markers that is not 
associated with a corresponding reduction in cell proliferation rates. 
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List of Abbreviations  
Ataxia-telangiectasia mutated kinase (ATM). 
β-galactosidase (SA-β gal). 
Cyclin dependent kinase (CDK). 
Cytochrome C (cyt c).  
DNA damage (DD).  
DNA damage repair (DDR). 
Double strand break (DSB). 
Dulbecco’s modified Eagle’s medium (DMEM) 
Fetal bovine serum (FBS). 
Immunofluorescence (IF). 
Immunohistochemistry (IHQ). 
Large tumor suppressor kinase 1 (LATS1). 
Mitochondrial electron transport chain (ETC). 
Mn superoxide dismutase (MnSOD). 
Mouse embryonic fibroblast (MEF). 
Non-homologous end-joining (NHEJ). 
8-oxo-deoxyguanosine (8-OH-dG).  
Passage (P). 
Peroxisome proliferator activated receptor γ co-activator 1α (PGC-1α). 
Phosphorylated histone H2AFX (γH2AFX). 
Population doubling level (PDLs) 
Reactive oxygen species (ROS). 
Terminal transferase (TdT). 
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Figure Legends 
Fig. 1.- PGC-1α-deficient MEFs show reduced levels of MnSOD and elvated levels of 
superoxide. A) Western blot analysis of cyt c, MnSOD and AMPK (total and phosphorylated) 
in serially-passed PGC-1α+/+ and PGC-1α-/- MEFs. β-actin was used as a loading control. Panel 
shows a representative western blot. B) Graphs show the quantitative analysis of the protein 
expression levels relative to those in PGC-1α+/+ MEFs, assigned a value of 1. Data represent 
means ± SD of passages 1–6. C) Confocal microscopy images of MitoSOXTM Red staining 
(40×) of PGC-1α+/+ and PGC-1α-/- MEFs at passage 1 (p1), p3 and p5. Scale bar, 20 µm. D) 
Quantitative analysis of MitoSOXTM Red images. Data represent the means ± SD, n=4 
independent cell cultures. *p < 0.05; **, p≤0.01; ***, p≤0.005.  
 
Fig. 2.- PGC-1α-deficient MEFs show increased levels of oxidative DNA damage and 
double-strand breaks. A) Representative immunofluorescence images of PGC-1α+/+ and PGC-
1α-/- MEFs showing TP53BP1/8-OH-dG nuclear foci (100×). Scale bar, 10 µm. B) Quantitative 
analysis of 8-OH-dG nuclear foci. C) Representative immunohistochemistry images of PGC-
1α+/+ and PGC-1α-/- MEFs showing DNA strand breaks labeled with biotinylated dUTP and 
TdT (60×). Scale bar, 10 µm. D) Quantitative analysis of DNA strand breaks. E) Representative 
imunoflorescence images of PGC-1α+/+ and PGC-1α-/- MEFs showing TP53BP1/γH2AFX foci 
(40×). Scale bar, 10 µm. F) Quantitative analysis of TP53BP1/γH2AFX foci (DDR foci). n=3 
independent cell cultures. Data represent the means ± SD. *, p≤0.05; **, p≤0.01; ***, p≤0.005. 
n=3. 
 
Fig, 3.- Evaluation of DNA damage repair. A) Representative immunofluorescence images of 
PGC-1α+/+ and PGC-1α-/- MEFs showing DDR foci (γH2AFX) at different times following 3 
Gy irradiation. Untreated (UN). Scale bar, 10 µm. B) Graph shows the % of cells with >10 DDR 
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foci. Untreated (UN). Scale bar, 10 µm. Data represent the means ± SD, n=3 independent cell 
cultures. *. The statistical analysis for the figure compares for the contrast WT vs KO at each 
time point the relative % distribution of cells with more or less than 10 foci per nucleus using 
paired T test p≤0.05, for the comparison of +/+ vs -/- MEFs at each of the indicated time 
points. 
 
Fig. 4.- PGC-1α-deficient MEFs present early senescence markers. A) Representative 
images of β-galactosidase staining in PGC-1α+/+ and PGC-1α-/- MEFs (10×). Scale bar, 100 µm. 
B) Quantification of cells positive for senescence-associated β-galactosidase activity. C)  
Western blot analysis of p53 (total and phosphorylated at Ser15), in serially-passaged PGC-
1α+/+ and PGC-1α-/- MEFs. β-actin was used as a loading control. D) qPCR mRNA and western 
blot analysis of p16, p19 and p21 in serially-passaged PGC-1α+/+ and PGC-1α-/- MEFs. β-actin 
was used as a loading control. Data for PGC-1α+/+ MEFs at passage 1 were assigned a value of 1 
or 100%. Data represent the means ± SD. Passage rans used to average values are indicated. 
Selected passage ranges are those within which the valu s did not change significantly. n=4 
independent cell cultures. *, p≤0.05; ***, p≤0,005. 
 
Fig. 5.- Growth rates, senescence arrest and escape of wild-type and PGC-1α-deficient 
MEFs. A) Population doubling level rates were calculated with the formula ∆Growth=Log2 
(nf/ni); where ni is the number of cells plated and nf is the number of cells before the next 
passage. The white background section indicates the difference in immortalization rates. B) 
Primary MEF growth rates. C) Immortalized MEF growth rates. Data represent the means ± SD, 
n=8. ***, p≤0.005. 
 
Fig. 6.- qRT-PCR analysis of mRNA levels of p53 target genes in wild-type and PGC-1α-
deficient MEFs at passage 5. Wild-type samples were assigned the value of 100%. Data are 
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Graphical Abstract. PGC-1α+/+ and PGC- 
 
Graphical Abstract.- PGC-1α deficient MEFs showed an exacerbated production of ROS 
compared to PGC-1α+/+ when serially passaged, these increased ROS levels were associated 
with the early induction of senescence markers. However, PGC-1α deficient MEFs maintained 
























































































We evaluated the role of PGC-1α on the induction of cellular senescence and immortalization. 
-The increase in ROS produccion associated with cell passage in MEFs is exacervated in PGC-
1α-/- MEFs. 
-PGC-1α-/- MEFs accumulate with cell passage higher levels of oxidative DNA damage than 
PGC-1α-+/+ MEFs. 
-Serially passaged PGC-1α-/- MEFs show en early induction of senescence markers that is not 
associated with a corresponding reduction in cell proliferation rates. 
-PGC-1α-/- MEFs, when serially passaged, inmortalize earlier than PGC-1α-+/+ MEFs. 
 
